Metropolis Healthcare Limited has submitted a regulatory filing to BSE Limited and the National Stock Exchange of India Limited regarding scheduled analyst and institutional investor meetings. The intimation is made pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Meeting Schedule Details
- June 03, 2026: Meeting with Morgan Stanley India commencing at 10:00 a.m. IST onwards, comprising both One to One and Group Meeting formats.
- June 11, 2026: Meeting with Choice Broking commencing at 10:00 a.m. IST onwards, comprising both One to One and Group Meeting formats.
Key Disclosures
The company explicitly states that all discussions during these interactions will be based exclusively on publicly available information. The disclosure confirms that no unpublished price sensitive information (UPSI) is intended to be discussed during any of these meetings.
Additional Information
The company notes that changes to the schedule may occur due to exigencies on the part of Participants, Host, or the Company itself. This intimation is also available on the company's official website at www.metropolisindia.com.